Comparison of hemostatic devices in endoscopic procedure

Comparison of new hemostatic devices for gastric endoscopic submucosal dissection: Coajet®versus.Hemograsper®

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0007005

Enrollment

Registered

2022-02-18

Start date

2022-02-22

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The Hemograspher group will have hemostatic treatment by cauterizing exposed blood vessels with electricity after grasping vessels, and the Coajet group will have hemostasis by contac

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Persons who have early gastric cancer or dysplasia 1. Age range 18-80 2. Sign the informed consent

Exclusion criteria

Exclusion criteria: 1. Previous history of endoscopic submucosal dissection 2. Uncontrolled severe cardiovascular, liver, lung, nervous system and psychiatric disorders / cancer or AIDS / other gastrointestinal or endocrine disorders 3. Who denied informed consent 4. Medication such as aspirin or clopidogrel, which affects bleeding 5. Previous history of gastrectomy of any reason

Design outcomes

Primary

Measure	Time frame
procedure time in both group (coajet group might have reduced time)	—

Secondary

Measure	Time frame
en-bloc resection rate, complete resection rate, complication rate	—

Countries

Korea, Republic of

Contacts

Public ContactSeong Woo Jeon

Kyungpook National University Medical Center

sw-jeon@hanmail.net+82-53-200-2602

Outcome results